1. Home
  2. ITOS vs MBCN Comparison

ITOS vs MBCN Comparison

Compare ITOS & MBCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • MBCN
  • Stock Information
  • Founded
  • ITOS 2011
  • MBCN 1901
  • Country
  • ITOS United States
  • MBCN United States
  • Employees
  • ITOS N/A
  • MBCN N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • MBCN Major Banks
  • Sector
  • ITOS Health Care
  • MBCN Finance
  • Exchange
  • ITOS Nasdaq
  • MBCN Nasdaq
  • Market Cap
  • ITOS 270.7M
  • MBCN 234.0M
  • IPO Year
  • ITOS 2020
  • MBCN N/A
  • Fundamental
  • Price
  • ITOS $10.02
  • MBCN $29.35
  • Analyst Decision
  • ITOS Hold
  • MBCN Hold
  • Analyst Count
  • ITOS 6
  • MBCN 1
  • Target Price
  • ITOS $10.60
  • MBCN $32.00
  • AVG Volume (30 Days)
  • ITOS 2.6M
  • MBCN 8.6K
  • Earning Date
  • ITOS 04-28-2025
  • MBCN 07-17-2025
  • Dividend Yield
  • ITOS N/A
  • MBCN 2.86%
  • EPS Growth
  • ITOS N/A
  • MBCN N/A
  • EPS
  • ITOS N/A
  • MBCN 2.00
  • Revenue
  • ITOS $35,000,000.00
  • MBCN $66,931,000.00
  • Revenue This Year
  • ITOS N/A
  • MBCN $15.08
  • Revenue Next Year
  • ITOS $31.74
  • MBCN $5.02
  • P/E Ratio
  • ITOS N/A
  • MBCN $14.64
  • Revenue Growth
  • ITOS 177.89
  • MBCN N/A
  • 52 Week Low
  • ITOS $4.80
  • MBCN $20.61
  • 52 Week High
  • ITOS $18.13
  • MBCN $34.00
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 73.75
  • MBCN 57.30
  • Support Level
  • ITOS $8.30
  • MBCN $28.66
  • Resistance Level
  • ITOS $11.35
  • MBCN $29.70
  • Average True Range (ATR)
  • ITOS 0.53
  • MBCN 0.63
  • MACD
  • ITOS 0.22
  • MBCN -0.10
  • Stochastic Oscillator
  • ITOS 71.15
  • MBCN 67.65

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About MBCN Middlefield Banc Corp.

Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.

Share on Social Networks: